| SciPort RLP

2016 - 2019

SUSTAIN

PD Dr. Julia,
Univ.-Prof. Dr. Andreas

2016 - 2017

VIOLET (17613): Efficacy and safety of three different Eylea regimens in subjects with DME

PD Dr. Katrin

2016 - 2018

BI 1320.22DME: Safety and effect on central retinal thickness of BI 1026706 in patients with diabetic macular edema

Dr. Katharina,
PD Dr. Katrin

2016 - 2017

CAPTAIN (469055): Correlation of functional and structural outcomes with serum antibody profiles in patients with neovascular age-related macular degeneration treated with ranibizumab and healthy subjects: a prospective, controlled monocenter trial

Dr. Christina

2016 - 2019

CA 209-473: A Multicenter, Randomized, Open-Label Study in Patients with Esophageal Cancer refractory or intolerant to Combination Therapy with Fluoropyrimidine and Platinum-based Drugs

Prof. Dr. Markus

2016 - 2019

A Phase III, open-label, multicenter trial of avelumab (MSB00107118C) as a third-line treatment of unresectable, recurrent, or metastatic gastric or gastroesophageal junction adenocarcinoma

Prof. Dr. Markus

2016 - 2018

STARflo MINIject

Univ.-Prof. Dr. Norbert,
PD Dr. Katrin

2016 - 2021

A Phase IIb/III prospective, randomized, double-blind, sham-controlled trail of 2-hydroxypropyl-beta-cyclodextrin (HP-beta-CD) in subjects with neurologic manifestations of Niemann-Pick Type C1 (NPC1) Disease

Univ.-Prof. Dr. Julia Beatrice,
Univ.-Prof. Dr. Jörg,
Prof. Dr. Irene

2016 - 2020

A Phase III open-label, multicenter trial of maintenance therapy with Avelumab* (MSB0010718C) versus continuation of first-line chemotherapy in subjects with unresectable, locally advanced or metastatic adenocarcinoma of the stomach or of the gastro-esophageal junction

Prof. Dr. Markus

2016

Control of Anaplasma phagocytophilum by interaction of neutrophil granulocytes and T-cells

PD Dr. Friederike

FB 04 - Universitätsmedizin

Johannes Gutenberg-Universität Mainz

Starten Sie Ihre Suche...

FB 04 - Universitätsmedizin

Johannes Gutenberg-Universität Mainz